Exome Asset Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Exome Asset Management’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.42M	Buy	576,960 +77,373	+15%	+$259K	0.73%	44
2025 Q4	$1.99M	Sell	499,587 -940,017	-65%	-$4.16M	0.95%	42
2025 Q3	$5.44M	Buy	+1,439,604	New	+$4.89M	3.3%	7
2024 Q3	–	Sell	-271,400	Closed	-$453K	–	72
2024 Q2	$453K	Sell	271,400 -54,362	-17%	-$97.1K	0.4%	48
2024 Q1	$606K	Buy	+325,762	New	+$600K	0.52%	49

Other funds holding NBP

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

ACM

AIHC Capital Management Central $120M AUM

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Exome Asset Management's NBP Position: Q1 2026 in Review

Exome Asset Management increased its NovaBridge Biosciences American Depositary Shares (NBP) stake by 15% in Q1 2026, buying an estimated $259K and bringing the position to 576,960 shares worth $1.42M. The position accounts for 0.73% of the portfolio, ranked #44.

Exome Asset Management first reported a position in NBP in Q1 2024 and has held it in 5 quarters since. The position peaked at $5.44M in Q3 2025. 48 funds tracked by Wall St. Rank hold NBP as of Q1 2026.

Exome Asset Management held 576,960 shares of NovaBridge Biosciences American Depositary Shares worth $1.42M as of Q1 2026.
Exome Asset Management bought 77,373 NovaBridge Biosciences American Depositary Shares shares in Q1 2026, an estimated $259K.
NovaBridge Biosciences American Depositary Shares made up 0.73% of Exome Asset Management's portfolio in Q1 2026, its #44 holding.
Exome Asset Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2024 and has held it in 5 quarters since.
Exome Asset Management's NovaBridge Biosciences American Depositary Shares position peaked at $5.44M in Q3 2025.
48 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2026.

Based on Exome Asset Management's 13F filing for Q1 2026, filed 15 May 2026.